Akglim-M 1 Tablet PR
By Akglim-M
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Akned Healthcare Pvt. Ltd.
F No-B 503, Plama Heights, Kalyan Nagar, Bangalore-560043 (Karnataka)

Expires on or after
July, 2025
About Akglim-M 1 Tablet PR
Akglim-M 1 Tablet PR is classified as an anti-diabetic medication and is a combination of two medicines specifically designed to manage type 2 diabetes mellitus in adults. The primary function of this drug is to regulate and stabilize blood sugar levels in individuals with diabetes. It is crucial to take Akglim-M 1 Tablet PR with food consistently at the same time each day in order to derive maximum benefits. The appropriate dosage of the medication will be determined by your doctor and may be adjusted periodically based on its efficacy in controlling your blood sugar levels.
It is important to emphasize the necessity of continued usage of Akglim-M 1 Tablet PR, even if you are feeling well or your blood sugar levels seem to be under control. Abrupt cessation of the medication without medical consultation may lead to a significant increase in blood sugar levels, potentially resulting in severe complications such as kidney damage, vision impairment, nerve issues, and even amputation. It should be noted that this medication forms just one component of a comprehensive treatment plan, which should also involve adherence to a healthy diet, engagement in regular physical activity, and weight management as recommended by your healthcare provider. Lifestyle modifications are instrumental in effectively managing diabetes.
One of the commonly reported side effects associated with Akglim-M 1 Tablet PR is low blood glucose levels (hypoglycemia), characterized by symptoms like sweating, dizziness, headaches, and trembling. To mitigate the risk of hypoglycemia, it is advisable to maintain a consistent meal schedule and carry a quick-acting glucose source like sugary snacks or fruit juice at all times. Consumption of alcohol can exacerbate the likelihood of experiencing low blood sugar levels and should be avoided while taking this medication. Other potential side effects may include alterations in taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory tract infections. Additionally, weight gain may be observed in some individuals using this medication.
Individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver conditions should refrain from taking Akglim-M 1 Tablet PR. It is imperative to inform your healthcare provider about any history of heart disease prior to commencing this medication, as it may not be suitable in such cases. Pregnant or breastfeeding women are advised to consult their doctor before initiating this treatment. Regular monitoring of blood sugar levels is essential, and periodic blood tests may be recommended to monitor blood cell counts and liver function throughout the course of treatment.
Benefits
Akglim-M 1 Tablet PR offers several benefits in the treatment of Type 2 diabetes mellitus. This combination medicine works by increasing the insulin production in your body, specifically in the pancreas. Insulin plays a crucial role in lowering blood glucose levels, which is essential for managing diabetes. By maintaining proper blood glucose levels with Gliplite M, you can reduce the risk of serious complications associated with diabetes, such as kidney damage, eye issues, nerve problems, and even limb loss.
It is recommended to take Akglim-M 1 Tablet PR once a day as prescribed by your healthcare provider. Consistent use of this medication, in conjunction with a balanced diet and regular exercise, can significantly contribute to leading a normal and healthy life. Glimepiride, a component of Gliplite M, works by stimulating pancreatic cells to produce insulin, aiding in the removal of sugar from the blood. Metformin PR, another key ingredient, is formulated for prolonged release, ensuring that the drug is released gradually over an extended period. Metformin helps in reducing sugar production by liver cells, slowing sugar absorption from the intestines, and enhancing muscle cell sensitivity to insulin. This combined action helps the cells effectively remove sugar from the blood, contributing to better glucose control in individuals with Type 2 diabetes.
In conclusion, Akglim-M 1 Tablet PR provides a comprehensive approach to managing Type 2 diabetes by addressing various aspects of glucose regulation. When used regularly and as directed, along with appropriate lifestyle modifications, this medication can support you in controlling your diabetes and reducing the risk of associated complications, ultimately enabling you to lead a healthier and more fulfilling life.
How to use the Akglim-M 1 Tablet PR
To properly use Akglim-M 1 Tablet PR, always follow your doctor's instructions or read the directions on the label before taking it. It is recommended to take this tablet with food. Additionally, for Gliplite M2 Tablet 10's, take it as directed by your doctor, swallowing the tablet whole with a glass of water. Avoid crushing or breaking the tablet. By following these guidelines, you can ensure that you are using Gliplite M tablets correctly for maximum effectiveness.
Uses of Akglim-M 1 Tablet PR
Akglim-M 1 Tablet PR is commonly prescribed for the treatment of Type 2 diabetes mellitus. It is effective in managing this condition by helping to regulate blood sugar levels. This medication is particularly useful for individuals diagnosed with Type 2 diabetes mellitus, as it assists in controlling the symptoms associated with this condition. Akglim-M 1 Tablet PR is beneficial in improving overall blood sugar control and can be a valuable addition to a comprehensive treatment plan for managing Type 2 diabetes mellitus.
What conditions Akglim-M 1 Tablet PR treats?
Akglim-M 1 Tablet PR is commonly used to manage type 2 diabetes, a chronic condition where the body struggles to use insulin effectively. This condition often affects middle-aged and older individuals, leading to symptoms such as frequent night urination, increased thirst, slow wound healing, fatigue, and blurred vision. Additionally, type 2 diabetes can result in complications like nerve issues, kidney problems, eye damage, limb loss, and increased risk of heart attack or stroke.
Should you consult a doctor?
If you experience any of the following symptoms while taking Akglim-M 1 Tablet PR, it is important to seek medical attention promptly. Signs of low blood sugar levels (hypoglycemia) may include sweating, dizziness, headache, and shaking. If you notice these symptoms, consult your doctor immediately. Additionally, if you have persistent side effects such as headache, nausea, or diarrhea that do not improve or if you are concerned about any reactions to the medication, it is advisable to seek medical advice. Remember, the wellbeing of your health is the priority, and any uncertainties should be addressed by a healthcare professional. It is recommended to keep your doctor informed about any changes in your health condition while using Akglim-M 1 Tablet PR to ensure its optimal effectiveness and safety for managing type 2 diabetes mellitus.
Side effects of Akglim-M 1 Tablet PR
When taking Akglim-M 1 Tablet PR, you may experience certain side effects. These side effects are usually mild and may go away as your body gets used to the medication. However, if these side effects persist or you are concerned about them, it is important to consult your doctor. Common side effects of Akglim-M 1 Tablet PR may include headaches, hypoglycemia (low blood glucose level), nausea, diarrhea, stomach pain, vomiting, and a metallic taste in the mouth. If you experience any of these side effects, it is advisable to seek medical advice to address your concerns and ensure your well-being.
Safety advice

liver
When it comes to the use of Akglim-M 1 Tablet PR, caution is advised for individuals with liver disease. It may be necessary to adjust the dosage of Akglim-M 1 Tablet PR in such cases, so it is crucial to consult with your doctor before starting the medication. Typically, Akglim-M 1 Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not recommended for use in individuals with severe liver disease. It is important to follow your healthcare provider's guidance closely to ensure safe and effective use of this medication.

kidney
Akglim-M 1 Tablet PR should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for guidance.

alcohol
It is not safe to mix alcohol with Akglim-M 1 Tablet PR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Akglim-M 1 Tablet PR to ensure safety.

pregnancy
Akglim-M 1 Tablet PR may be unsafe during pregnancy. Limited human studies suggest risks to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this medication.

breastfeeding
Caution Akglim-M 1 Tablet PR is not safe to use while breastfeeding as it may cause toxicity to the baby.
Consumption warning before consuming Akglim-M 1 Tablet PR
Before consuming Akglim-M 1 Tablet PR, it is crucial to consider several important points. Firstly, if you have any allergies to Gliplite M2 Tablet 10's or any other medications, inform your doctor promptly. This medication is not suitable for children, and if you are breastfeeding, it is advisable to avoid taking it as it may pass into breast milk. For pregnant individuals or those planning pregnancy, consulting your doctor is vital as it could potentially harm the unborn baby. Alcohol consumption should be avoided as it can raise the risk of lactic acidosis.
Additionally, only drive if you are fully alert whilst on Gliplite M2 Tablet 10's, and maintain a routine of short, regular meals to prevent prolonged fasting. Be vigilant for signs of hypoglycemia such as sweating, dizziness, intense thirst, and consult your doctor immediately if any symptoms occur. Always carry sweets, glucose biscuits, or sugar for quick relief, especially during long journeys. These precautions are essential for safe and effective use of Akglim-M 1 Tablet PR.
What if you forgot to take Akglim-M 1 Tablet PR?
If you forget to take your scheduled dose of Akglim-M 1 Tablet PR, try to take it as soon as you remember. But if it is close to the time for your next dose, it's better to skip the missed dose and continue with your usual dosing schedule. Avoid taking a double dose to make up for the missed one. It is important to maintain a consistent dosing routine to ensure the effectiveness of the medication.
Related lab tests
For individuals taking Akglim-M 1 Tablet PR, it is important to monitor certain lab tests to ensure the medication is working effectively and to check for any potential side effects. Related lab tests include:
1. Glucose - Fasting Blood: This test measures the amount of glucose in the blood after fasting for a certain period of time, typically overnight. It helps in diagnosing and monitoring diabetes and assessing the effectiveness of medications like Gliplite M in controlling blood sugar levels.
2. Glucose - Postprandial Blood: This test measures the blood glucose levels after consuming a meal. It is helpful in evaluating how well the body is processing sugar after eating and can provide additional insight into blood sugar control.
3. Glycosylated Hemoglobin (HbA1c): This test determines the average blood sugar levels over the past 2-3 months by measuring the percentage of glucose bound to hemoglobin in red blood cells. It is a key indicator of long-term glucose control and is often used in managing diabetes treatments like Gliplite M.
Regular monitoring of these lab tests can help healthcare providers assess the efficacy of treatment with Gliplite M and make necessary adjustments if needed to ensure optimal diabetes management.
Additional Information
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹120
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024